Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
D000313:Adrenal Medulla / Q000503:physiopathology; D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002396:Catechols / Q000378:metabolism*; D004837:Epinephrine / Q000378:metabolism / Q000652:urine; D005260:Female; D006018:Glycols / Q000378:metabolism*; D006801:Humans; D008094:Lithium / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism* / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D013564:Sympathetic Nervous System / Q000503:physiopathology; D014642:Vanilmandelic Acid / Q000652:urine
D002395:Catecholamines; D002396:Catechols; D006018:Glycols; D009647:Normetanephrine; D014642:Vanilmandelic Acid; D008094:Lithium; D009638:Norepinephrine; D004837:Epinephrine